Systemic Administration of siRNA with Anti-HB-EGF Antibody-Modified Lipid Nanoparticles for the Treatment of Triple-Negative Breast Cancer
Ayaka Okamoto(University of Shizuoka), Naoto Oku(University of Shizuoka), Yusuke Hirai(University of Shizuoka), Tomohiro Asai(University of Shizuoka), Tetsuo Minamino(Kagawa University), Kosuke Shimizu(Hamamatsu Photonics (Japan)), Hiroyuki Koide(University of Shizuoka)
Cited by 77
Related Papers
Recognition, Neutralization, and Clearance of Target Peptides in the Bloodstream of Living Mice by Molecularly Imprinted Polymer Nanoparticles: A Plastic Antibody
|Journal of the American Chemical Society|2010|486
Tyrosine Phosphorylation of β-Catenin and Plakoglobin Enhanced by Hepatocyte Growth Factor and Epidermal Growth Factor in Human Carcinoma Cells
|Cell Communication & Adhesion|1994|417
Metformin Prevents Progression of Heart Failure in Dogs
|Circulation|2009|288
Ablation of C/EBP Homologous Protein Attenuates Endoplasmic Reticulum–Mediated Apoptosis and Cardiac Dysfunction Induced by Pressure Overload
|Circulation|2010|281
Arachidonic acid-selective cytosolic phospholipase A2 is crucial in the cytotoxic action of tumor necrosis factor
|Journal of Biological Chemistry|1993|256